<?xml version="1.0" encoding="UTF-8"?>
<p>All three CoVs are listed in the WHO Blueprint list for priority pathogens for research because of their epidemic potential and lack of effective treatments. SARS-CoV was first identified in humans in Guangdong, China, in November, 2002 and subsequently spread rapidly worldwide to 29 countries, resulting in 8098 human SARS cases with 774 deaths (9.6% mortality) [
 <xref rid="B12" ref-type="bibr">12</xref>]. The SARS epidemic ended abruptly in July, 2003, and no human cases of SARS have been detected since 2004. MERS-CoV was first isolated from a lung sample of an adult patient who died of pneumonia at the Al-Fakieh hospital in Jeddah, Saudi Arabia. MERS-CoV. A retrospective study then linked MERS-CoV to a hospital outbreak in April, 2012, in Jordan [
 <xref rid="B13" ref-type="bibr">13</xref>]. Dromedaries and camels are implicated as the zoonotic source of infection [
 <xref rid="B14" ref-type="bibr">14</xref>]. MERS-CoV continues to circulate and cause human disease with intermittent community clusters, and nosocomial outbreaks in the Middle East. MERS-CoV continues to cause human disease and as of Feb 29, 2020, there have been 2494 laboratory-confirmed human cases of MERS-CoV infection, with 858 deaths (34Â·0% mortality) reported from 27 countries in all continents, the majority of which were reported by Saudi Arabia (2106 cases, 780 deaths) [
 <xref rid="B15" ref-type="bibr">15</xref>].
</p>
